servier’s

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric…

3 weeks ago

Servier’s Voranigo (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and the Prix Galien Bridges Awards for Best Product…

4 months ago